QuantLogix ← MDT scorecard
📅 MDT Earnings Preview
Medtronic plc
Next report (est.)
May 24, 2026
Countdown
Imminent
EPS growth YoY
+8.1%
Revenue growth YoY
+6.6%
Options-implied earnings move
±2.5%
The at-the-money straddle prices a move to roughly $82.19 or $78.21 from $80.20 by June 18, 2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
November 25, 2025 ±3.2% +2.1% over-priced
August 26, 2025 ±3.4% +0.1% over-priced
February 25, 2025 ±3.7% +0.3% over-priced
November 26, 2024 ±2.2% -0.1% over-priced
August 27, 2024 ±2.5% -0.6% over-priced
February 27, 2024 ±2.6% +0.2% over-priced
November 30, 2023 ±1.3% +0.5% over-priced
August 31, 2023 ±1.9% -1.0% over-priced
Across these reports, options implied an average ±2.6% move vs an actual average of 0.6% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $1.07 $9.0B $1.4B
Q1 FY2026 $0.81 $8.6B $1.0B
Q4 FY2025 $0.82 $8.9B $1.1B
Q3 FY2025 $1.01 $8.3B $1.3B
Live 5-factor engine read: Neutral · 44/100 Full scorecard →
Get alerted before every MDT report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on MDT before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Medtronic plc (MDT) reports imminently, with the next report estimated for May 24, 2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 0.6% on average — the market has systematically over-priced MDT's earnings risk. Fundamentals into the print: EPS up 8.1% year-over-year, revenue up 6.6%. QuantLogix's live 5-factor engine currently reads MDT as a neutral at 44/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →